C-squared Pharma Ltd, based in Ireland, is a pharmaceutical company.
One of their notable products is ATROPINE SULFATE USP, with a corresponding US DMF Number 30605.
Remarkably, this DMF maintains an Active status since its submission on September 09, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 23, 2017, and payment made on November 18, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II